Fermata
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Fermata was an Israeli agtech startup founded in 2019 that aimed to produce sustainable, animal-free proteins using precision fermentation. It raised $5 million from investors including Precision Capital and Kibbutz Ketura, pursuing laboratory proof-of-concept for fermentation-made proteins.
02 / Fermata FAILURE REASONS
Failure reasons
Fermata shut down in 2024 after five years because it ran out of capital before reaching commercial viability. The $5 million covered initial R and D and proof-of-concept, but was far too little for the expensive scale-up from laboratory success to commercial precision fermentation. This financing gap between lab and commercial production is a common cause of death for deep-tech biotech startups.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Fermata is founded in Israel to develop animal-free proteins via precision fermentation.
- Closure announced
After raising $5 million and operating for five years, Fermata shuts down, having exhausted its capital before commercial viability.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Animal-free proteins via precision fermentation
- 02
Founded 2019 in Israel; $5M raised
- 03
Lab proof-of-concept; scale-up too costly
- 04
Shut down 2024; capital exhausted